KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,480,644 | -23.4% | 44,241 | -1.7% | 0.01% | -14.3% |
| Q2 2023 | $9,763,236 | -33.7% | 45,023 | -44.6% | 0.01% | -41.7% |
| Q1 2023 | $14,731,397 | +5.5% | 81,269 | +14.4% | 0.01% | +9.1% |
| Q4 2022 | $13,958,181 | -9.9% | 71,034 | +3.1% | 0.01% | -21.4% |
| Q3 2022 | $15,500,000 | +47.9% | 68,913 | -16.8% | 0.01% | +55.6% |
| Q2 2022 | $10,483,000 | -36.0% | 82,864 | -35.9% | 0.01% | -18.2% |
| Q1 2022 | $16,391,000 | -3.6% | 129,277 | -0.4% | 0.01% | 0.0% |
| Q4 2021 | $17,007,000 | +8.9% | 129,823 | +1.7% | 0.01% | 0.0% |
| Q3 2021 | $15,618,000 | +7.1% | 127,671 | -0.2% | 0.01% | +10.0% |
| Q2 2021 | $14,580,000 | -11.9% | 127,906 | -7.1% | 0.01% | -16.7% |
| Q1 2021 | $16,545,000 | +16.0% | 137,611 | -2.0% | 0.01% | +9.1% |
| Q4 2020 | $14,261,000 | +39.7% | 140,376 | +6.3% | 0.01% | +22.2% |
| Q3 2020 | $10,209,000 | +16.3% | 132,033 | +67.7% | 0.01% | +12.5% |
| Q2 2020 | $8,777,000 | – | 78,743 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |